Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples